Methodological issues in evaluating measures of health as outcomes for COPD

The selection of an appropriate outcome measure depends on the aspect of the disease being addressed and the purpose of the study being conducted. The most fundamental property of any outcome is its ability to measure the biological variable under question. Other properties such as discriminative and evaluative abilities are also important. Specific outcomes measure a single biological variable, such as forced expiratory volume in one second or depression. The specificity of such measures is attractive but requires precise definition of what is being measured and why. Other, summative, outcomes are used to quantify the overall effect of a number of different biological processes. The simplest summative measures are global questions such as “How would you rate your health overall?” Others are complex with many items. If designed and used correctly, these questionnaires can provide an estimate of the overall impact of disease or response to therapy and an index of whether that response was clinically worthwhile. Standardisation of measurements is important to permit comparisons between patients and studies, which makes the measurement of an individual's “quality of life” difficult. The term “health-status measurement” may be better when referring to the use of standardised questionnaires. Utility-based measures help address concerns regarding clinical versus statistical improvement and place outcomes for chronic obstructive pulmonary disease treatment trials in the context of all healthcare treatments.

[1]  P. Dolan,et al.  Health state valuations from the general public using the Visual Analogue Scale , 1996, Quality of Life Research.

[2]  D. Feeny,et al.  Methods for assessing relative importance in preference based outcome measures , 1993, Quality of Life Research.

[3]  P. Jones Interpreting thresholds for a clinically significant change in health status in asthma and COPD , 2002, European Respiratory Journal.

[4]  P. Jones,et al.  Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.

[5]  P. Jones,et al.  Health Status measurement: an increasingly important outcome evaluation in COPD patients. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[6]  L. Russell,et al.  The methodologic partnership of effectiveness reviews and cost-effectiveness analysis. , 2001, American journal of preventive medicine.

[7]  R. Zuwallack,et al.  Quality of Life Evaluation and Survival Study: a 3-yr prospective multinational study on patients with chronic respiratory failure. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[8]  C. Browne,et al.  Quality of life following total hip replacement. , 2000, Irish medical journal.

[9]  F. Dorey,et al.  The accuracy of assessing total hip arthroplasty outcomes: a prospective correlation study of walking ability and 2 validated measurement devices. , 2000, The Journal of arthroplasty.

[10]  P. Herberts,et al.  Outcome after total hip arthroplasty: Part I. General health evaluation in relation to definition of failure in the Swedish National Total Hip Arthroplasty register , 2000, Acta orthopaedica Scandinavica.

[11]  R. Kaplan,et al.  Two pathways to prevention. , 2000, The American psychologist.

[12]  L. Russell • Improving the Panel's Recommendations , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  P. Jones,et al.  A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma. , 1999, The European respiratory journal.

[14]  M. Cross,et al.  Outcomes after hip or knee replacement surgery for osteoarthritis , 1999, The Medical journal of Australia.

[15]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[16]  Hannah McGee,et al.  Individual Quality of Life: Approaches to Conceptualisation and Assessment , 1999 .

[17]  G. Guyatt,et al.  Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. , 1999, Journal of clinical epidemiology.

[18]  R. Mulhern,et al.  A framework for assessing health‐related quality of life among children with cancer , 1999, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[19]  R M Kaplan,et al.  The Quality of Well-Being Scale: critical similarities and differences with SF-36. , 1998, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[20]  J E Ware,et al.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. , 1998, Journal of clinical epidemiology.

[21]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[22]  R. Kaplan,et al.  Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. , 1998, Chest.

[23]  Robert M. Kaplan,et al.  The quality of well-being scale: Comparison of the interviewer-administered version with a self-administered questionnaire , 1997 .

[24]  P. Kind,et al.  Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). , 1997, British journal of rheumatology.

[25]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[26]  L. Goldman,et al.  Health-related quality of life after elective surgery: measurement of longitudinal changes. , 1997, Journal of general internal medicine.

[27]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[28]  M C Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[29]  M. Gold,et al.  Panel on cost-effectiveness in health and medicine. , 1996, Medical care.

[30]  G. Guyatt,et al.  Assessing the minimal important difference in symptoms: a comparison of two techniques. , 1996, Journal of clinical epidemiology.

[31]  M. Weinstein,et al.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine. , 1996, JAMA.

[32]  R. Kaplan,et al.  Patients’ self-reports of dyspnea: An important and independent outcome in chronic obstructive pulmonary disease , 1996, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[33]  M. Belman,et al.  Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[34]  R. Glueckauf,et al.  Psychological practice in a changing health care system : issues and new directions , 1996 .

[35]  R. Kaplan,et al.  Quality of well-being predicts survival in lung transplantation candidates. , 1995, American journal of respiratory and critical care medicine.

[36]  A. Ries,et al.  Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995, Annals of Internal Medicine.

[37]  P. Jones,et al.  Issues concerning health-related quality of life in COPD. , 1995, Chest.

[38]  R M Kaplan,et al.  Validity of the Quality of Well-Being Scale for Persons With Human Immunodeficiency Virus Infection , 1995, Psychosomatic medicine.

[39]  R. Kaplan,et al.  Annals of Internal Medicine Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995 .

[40]  G W Torrance,et al.  Multi-attribute health status classification systems. Health Utilities Index. , 1995, PharmacoEconomics.

[41]  R. Kaplan,et al.  Reliability and validity of dyspnea measures in patients with obstructive lung disease , 1995, International journal of behavioral medicine.

[42]  R. Kaplan Using quality of life information to set priorities in health policy , 1994 .

[43]  R. Kaplan An outcomes-based model for directing decisions in women's health care. , 1994, Clinical obstetrics and gynecology.

[44]  R. Kaplan,et al.  Outcome measurement in kidney disease. , 1994, Blood purification.

[45]  R M Kaplan,et al.  The Ziggy theorem: toward an outcomes-focused health psychology. , 1994, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[46]  D. O’Donnell,et al.  Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. , 1993, The American review of respiratory disease.

[47]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[48]  R. Kaplan,et al.  Measuring the quality of well-being in cystic fibrosis and lung transplantation. The importance of the area under the curve. , 1991, Chest.

[49]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[50]  R M Kaplan,et al.  Behavior as the central outcome in health care. , 1990, The American psychologist.

[51]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[52]  G H Guyatt,et al.  Responsiveness and validity in health status measurement: a clarification. , 1989, Journal of clinical epidemiology.

[53]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[54]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[55]  G. Huston The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[56]  R A Deyo,et al.  Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. , 1986, Journal of chronic diseases.

[57]  G. Guyatt,et al.  The role of before-after studies of therapeutic impact in the evaluation of diagnostic technologies. , 1986, Journal of chronic diseases.

[58]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.

[59]  R. Kaplan,et al.  Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. , 1984, Journal of chronic diseases.

[60]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.